Particle.news
Download on the App Store

Study Finds Nitazene Overdose Deaths Far Higher Than Counts as Drugs Vanish From Tests

New modeling finds routine toxicology delays plus chemical instability hide many fatalities.

Overview

  • Researchers from King’s College London report in Clinical Toxicology that only about 14% of nitazene present at overdose remains detectable after a typical month-long UK analysis delay.
  • They estimate actual nitazene-related deaths are roughly one third higher than official figures because routine post-mortem testing often misses the rapidly degrading compounds.
  • The EU Drugs Agency says about half of the nearly 50 new substances notified in 2024 across the EU were nitazenes, reflecting a sharp market expansion over seven years.
  • The UK’s National Crime Agency recorded more than 330 nitazene-linked deaths in 2024, with many victims reported to be very young.
  • In Germany, toxicology was performed in only 40% of drug deaths in 2024; authorities logged 32 deaths involving synthetic opioids, including nine with nitazenes, while frequent polydrug use (about 80% of cases) complicates cause-of-death attribution.